Антибиотикорезистентность в стационаре: контролируем ли мы ситуацию?

1. Haley R. W., Culver D. H., White J. W. et al. Am J Epidemiol 1985; 121:159-167.

2. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, data summary from January 1996 through December 1997: a report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1999; 27: 279-284.

3. Centers for Disease Control and Prevention. Detailed ICU surveillance component: national nosocomial infection surveillance scheme 1-80. Atlanta, GA: Centers for Disease Control and Prevention, 1997.

4. Esen S., Leblebicioglu H. Scand J Infect Dis 2004; 36: 2: 144-148.

5. Richards M. J., Edwards J. R., Culver D. H., Gaynes R. P. National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27: 5: 887-892.

6. Vincent J. L., Bihari D. J., Suter P. M. et al. JAMA 1995; 274: 639-644.

7. Vincent J. L. Intensive Care Med 2000; 26: Suppl1: S3-8.

8. Clark N. M., Hershberger E., Zervos M. J., Lynch J. P. Curr Opin Crit Care 2003; 9: 403-412.

9. Linares J. Clin Microbiol Infect 2001; 7: Suppl 4: 8-15.

10. Cosgrove S. E., Sakoulas G., Parencevich E. N. et al. Clin Infect Dis 2003; 36: 53-59.

11. Gonzales C., Rubio M., Romero-Vivas J. et al. Clin Infect Dis 1999; 29: 1171-1177.

12. Eguia J., Chambers H. Semin Resp Crit Care Med 2003; 24: 37-48.

13. Wunderink R. G., Rello J., Cammarata S. K. et al. Chest 2003; 124: 1789-1797.

14. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control 2002; 30: 458-475.

15. Weber S., Gold H. Semin Resp Crit Care Med 2003; 24: 49-60.

16. Nathisuwan S., Burgess D. S., Lewis J. S. Pharmacotherapy 2001; 21: 8: 920-928.

17. Knothe H., Shah P., Kremery V. et al. Infection 1983; 11: 315-317.

18. Babini G. S., Livermore D. M. J Antimicrob Chemother 2000; 45: 183-189.

19. Fluit A. C., Jones M. E., Schmitz F. J. et al. Clin Infect Dis 2000; 30: 454-460.

20. Gunseren F., Mamikoglu L., Ozturk S. et al. J Antimicrob Chemother 1999; 43: 373-378.

21. Сидоренко С. В., Резван С. П., Еремина Л. В. и др. Антибиотики и химиотер 2005; 50: 2-3: 33-41.

22. Paterson D. L. Curr Opin Infect Dis 2001; 14: 697-701.

23. Rahal J. J. Clin Microb Infect 2000; 6: Suppl 2: 2-6.

24. Paterson D. L. 21st ICC, Birmingham, 1999. Abstract.

25. Schiappa D. A., Hayden M. K., Matushek M. G. et al. J infect Dis 1996; 174: 529-536.

26. Andes D., Craig W. A. 41th Interscience Conference on Antimicrobial Agents and Chemotherapy, December 2001; Abstract.

27. Березин А. Г., Ромашов О. М., Яковлев С. В., Сидоренко С. В. Антибиотики и химиотер 2003; 48: 7: 2-8.

28. Gutmann L., Heritier C., Nordmann P. et al. Antimicrob Agents Chemother 2003; 47: 755-758.

29. Pollack M. Pseudomonas aeruginosa. In: Principles and Practice of Infectious Diseases, 4th ed. / Ed. By Mandell G. L., Bennett J. E., Dolin R. Churchill Livingstone, London, UK, 1995; 1980-2003.

30. Giamarellou H. J Antimicrob Chemother 2002; 49: 229-233.

31. Страчунский Л. С., Решедько Γ. Κ., Стецюк О. У. и др. Клин микробиол антимикроб химиотер 2003; 5: 1: 35-46.